Login / Signup

Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. Authors' reply.

Eduardo Vilar-GomezNaga Chalasani
Published in: Alimentary pharmacology & therapeutics (2020)
Keyphrases
  • liver fibrosis
  • replacement therapy